Immunotherapy Using T Cell Defined Tumor Antigens for Melanoma-Reference-Cited by-同舟云学术

Immunotherapy Using T Cell Defined Tumor Antigens for Melanoma

Published:1998-12 Issue:12 Volume:42 Page:803-813
ISSN:0385-5600
Container-title:Microbiology and Immunology
language:en
Short-container-title:Microbiology and Immunology

Author:

Kawakami Yutaka¹

Affiliation:

1. Division of Cellular Signaling; Institute for Advanced Medical Research, Keio University School of Medicine; 35 Shinanomachi Shinjuku-ku Tokyo 160-8582 Japan

Publisher

Wiley

Subject

Virology,Immunology,Microbiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1348-0421.1998.tb02355.x/fullpdf

Reference61 articles.

1. Heat shock protein peptide complexes, reconstituted in vitro, elicit peptide specific cytotoxic T lymphocyte response and tumor immunity;Blachere;J. Exp. Med.,1997

2. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas;Brichard;J. Exp. Med.,1993

3. A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes;Brichard;Eur. J. Immunol.,1996

4. Heterogeneous expression of melanoma-associated antigens and HLA-A2 in metastatic melanoma in vivo.;Cormier;Int. J. Cancer,1998

5. Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A;Cormier;Cancer J. Sci. Am.,1997

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic Identification of Human Melanoma Antigens Using Serial Analysis of Gene Expression (SAGE);Journal of Immunotherapy;2005-01

2. Inhibition of melanoma growth after treatment with dendritic cells in a Tyr-SV40E murine model requires CD4+ T cells but not CD8+ T cells;Melanoma Research;2004-12

3. Preferentially Expressed Antigen of Melanoma (PRAME) in the Development of Diagnostic and Therapeutic Methods for Hematological Malignancies;Leukemia & Lymphoma;2003-01

4. Decline in MHC class I expression with increasing thickness of cutaneous melanomas in standard-strain transgenic mouse models;Melanoma Research;2002-06

5. Isolation of a New Melanoma Antigen, MART-2, Containing a Mutated Epitope Recognized by Autologous Tumor-Infiltrating T Lymphocytes;The Journal of Immunology;2001-02-15